Manipur extends lockdown while Meghalaya , Sikkim reports fresh cases

▴ Manipur extends lockdown while Meghalaya , Sikkim reports fresh cases
North-East Coronavirus news update Aug 7 2020

Manipur extends lockdown til August 15

The Manipur government has extended the ongoing complete lockdown and curfew in the state till the 15th of August in view of the rise in COVID-19 cases.

The entire state was under complete lockdown and curfew from 23rd July till yesterday to contain the spread of the deadly virus.

A Cabinet meeting led by Manipur Chief Minister N. Biren Singh was held last evening to review the crisis. During the meeting, the decision was taken to extend the ongoing complete lockdown in the state till the 15th of this month.

An official order issued by the State Chief Secretary said, certain relaxations will be allowed during this period. All locality-based retails shops dealing with essential commodities will be opened in all districts from 8 am to 12 noon on all days except Sundays.

Moreover, certain parts of the Imphal market and other markets in districts will be opened on a roster basis to cater the requirement of retailers.

22 new COVID-19 cases detected in Meghalaya

In Meghalaya, 22 new COIVID-19 cases were detected today taking the total active positive case to 595.

Director of Health Services, Dr. Aman War said that out of the 22 new cases, 19 were from East Khasi Hills district and all were civilians, one BSF personnel in West Garo Hills district, and two civilians in South West Garo Hills district.

Out of the 595 total COVID 19 cases that have been detected in Meghalaya, East Khasi Hills district has 487 cases which include 188 BSF personnel, 241 civilians and 58 Armed Force personnel. In other districts, West Khasi Hills-5, Ri-Bhoi-51, West Jaintia Hills-16, East Jaintia Hills-17, West Garo Hills-15, South West Garo Hills-2 and South Garo Hills-2.

So far 39,553 samples have been sent for testing out of which 38,062 were found negative and results of 552 are awaited. The total number of recovered cases is 339.

29 security personnel test COVID-19 positive in Mizoram
AIR PicsIn Mizoram 33 fresh Coronavirus positive cases including 29 security personnel were detected during the last 24 hours. Also, four patients were discharged after recovery yesterday.

With this, the total number of COVID-19 cases in the state has reached 537 and a total of 286 patients have been discharged after recovery from the infections.

According to the official statement, the number of active cases in the state presently stands at 251. The recovery rate presently stands at 53.25%.

Tags : #SikkimCoronaNews #ManipurCoronaNews #MeghalayaCoronaNews #NorthEastIndiaCoronaNewsUpdateAug7

About the Author


Team Medicircle

Related Stories

02 Aug

Sweet Poison: Heavy Metal Contamination in Chocolate

While chocolates and cocoa-based products are generally safe to consume in moderation, it is essential to be aware of the potential risks associated with heavy metal contamination.

View
18 Mar

FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation Therapy

Lupin Limited's FDA approval for its generic Varenicline tablets marks a significant milestone in the field of smoking cessation therapy.

View
17 Nov

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need for broader insurance coverage to ensure accessibility for a larger population.

View
16 Nov

Combatting Chikungunya: Valneva's Chikungunya Vaccine Cleared by USFDA, Eyes India Launch

As Valneva works towards making this groundbreaking vaccine available in India, the collaboration with CEPI and Instituto Butantan underlines the global effort to address infectious diseases. The upcoming regulatory interactions with DCGI will shed light on the timeline for Ixchiq's launch in India.

View
11 Nov

Historic Breakthrough: FDA Grants Accelerated Approval for Valneva’s Ixchiq - The First Chikungunya Vaccine

As the vaccine moves towards global markets, its impact on public health is poised to be substantial. The ongoing commitment to safety studies and pediatric evaluations reflects a dedication to comprehensive healthcare solutions. The pharmaceutical landscape is witnessing a transformative moment, and Ixchiq stands at the forefront of this medical breakthrough.

View
03 Nov

A New Hope for Sickle Cell Patients: Groundbreaking Gene Therapy Under FDA Review

Unlike current treatments that include drugs, blood transfusions, and bone marrow transplants, exa-cel aims to provide a one-time, DNA-altering solution. By modifying the patient's blood cells, the therapy targets the root cause of the disease, promoting the production of healthy haemoglobin.

View
23 Oct

Indian Medtech Startup Sigtuple Receives U.S. FDA approval; becomes India's 1st company in this space to earn the clearance

For all haematological disorders like blood cancers, infections, anaemia & allergies, the microscopic examination of the peripheral blood smear (PBS) is the gold standard test, but microscopy today is predominantly a manual process - necessitating a highly skilled pathologist to be present on-site.

View
06 Oct

Safety Concerns Arise: FDA Investigates Probiotic-Related Infant Death

Probiotics are live microorganisms believed to enhance health when consumed adequately, while they offer potential health benefits, this incident highlights the importance of careful consideration, especially in vulnerable populations like preterm infants.

View
05 Aug

FDA Approves Groundbreaking Postpartum Depression Oral Pill - Zurzuvae (Zuranolone)

Postpartum depression (PPD) affects countless new mothers worldwide, casting a shadow over what should be a joyful time in their lives. For years, healthcare professionals have been searching for an effective treatment for this debilitating condition. In a momentous development, the U.S. Food and Drug Administration (FDA) has recently approved the first-ever postpartum depression oral pill, Zurzuvae (Zuranolone).

View
23 Feb

4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029

Latest Pharma news

View

-Advertisements-




Trending Now

Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025
Type 2 Diabetes Under Attack: The Unexpected Power of Wearable TechMarch 28, 2025
Research identifies causes of catastrophic floodingMarch 28, 2025
Why a Few Extra Inches Around Your Waist Could Cost You Your LifeMarch 28, 2025
Young IT Professional Answers Call To Be Stem Cell DonorMarch 28, 2025
5 Hidden Signs of Nutrient Deficiency You Shouldn’t IgnoreMarch 28, 2025